Yonsei Med J.  1998 Dec;39(6):534-540. 10.3349/ymj.1998.39.6.534.

Molecular analysis of fluoroquinolone-resistance in Escherichia coli on the aspect of gyrase and multiple antibiotic resistance (mar) genes

• Park YH
• Yoo JH
• Huh DH
• Cho YK
• Choi JH
• Shin WS

• KMID: 711595
• DOI: http://doi.org/10.3349/ymj.1998.39.6.534

Abstract

We analyzed the fluoroquinolone resistance mechanism of 28 isolates of ciprofloxacin-resistant E. coli from patients who received ciprofloxacin as a regimen of a selective gut decontamination. Isolates distinctive by infrequent restriction site polymerase chain reaction (IRS-PCR) were subjected to Hinf I restriction fragment length polymorphism analysis, single-stranded conformation polymorphism (SSCP), and nucleotide sequencing of the quinolone resistance determining region (QRDR) in gyrA. Double mutations in QRDR of gyrA (Ser83 Leu and Asp87Asn) were found from most of the strains. Nucleotide sequencing of the marR locus showed that 18 out of 28 (64%) ciprofloxacin-resistant E. coli strains had three types of base change in marR loci: a double-base change at nucleotides 1628 and 1751, or 1629 and 1751: and a single-base change at 1751. However, all the mutated strains showed no tolerance to cyclohexane test, suggesting the mutation in the marR region had no influence on overexpression of the MarA protein. In conclusion, mutation in gyrA was the main mechanism of ciporfloxacin resistance in E. coli from patients with selective gut decontamination. Therefore, mutation in the mar region did not influence the levels of ciprofloxacin resistance in our isolates.

Keyword

Fluoroquinolone-resistant E. coli; marR; mar mutation; gyrA

MeSH Terms

Ciprofloxacin/pharmacology*
DNA Topoisomerase (ATP-Hydrolysing)/genetics*
Drug Resistance, Microbial/genetics*
Drug Resistance, Multiple/genetics*
Escherichia coli/genetics
Escherichia coli/drug effects*
Human
Mutation/physiology